Shopping Cart
- Remove All
Your shopping cart is currently empty
Bavachalcone, a major bioactive compound isolated from *Psoralea corylifolia* L., may serve as a therapeutic drug for bone resorption-associated diseases. It protects endothelial function by increasing AMPK activity and MnSOD expression while reducing mitochondrial oxidative stress.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $47 | In Stock | |
| 5 mg | $108 | In Stock | |
| 10 mg | $162 | In Stock | |
| 25 mg | $293 | In Stock | |
| 50 mg | $439 | In Stock | |
| 100 mg | $635 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $118 | In Stock |
| Description | Bavachalcone, a major bioactive compound isolated from *Psoralea corylifolia* L., may serve as a therapeutic drug for bone resorption-associated diseases. It protects endothelial function by increasing AMPK activity and MnSOD expression while reducing mitochondrial oxidative stress. |
| In vitro | bavachalcone has excellent anticancer ability among other components of C. corylifolium by inducing apoptosis and autophagy[3]. |
| Molecular Weight | 324.37 |
| Formula | C20H20O4 |
| Cas No. | 28448-85-3 |
| Smiles | CC(C)=CCc1cc(C(=O)\C=C\c2ccc(O)cc2)c(O)cc1O |
| Relative Density. | 1.243g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 34 mg/mL (104.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.